Cardio Change To Liabilities vs End Period Cash Flow Analysis
| CDIO Stock | USD 1.08 0.30 38.46% |
Cardio Diagnostics financial indicator trend analysis is way more than just evaluating Cardio Diagnostics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cardio Diagnostics is a good investment. Please check the relationship between Cardio Diagnostics Change To Liabilities and its End Period Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Change To Liabilities vs End Period Cash Flow
Change To Liabilities vs End Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cardio Diagnostics Change To Liabilities account and End Period Cash Flow. At this time, the significance of the direction appears to have pay attention.
The correlation between Cardio Diagnostics' Change To Liabilities and End Period Cash Flow is -0.73. Overlapping area represents the amount of variation of Change To Liabilities that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Cardio Diagnostics Holdings, assuming nothing else is changed. The correlation between historical values of Cardio Diagnostics' Change To Liabilities and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Liabilities of Cardio Diagnostics Holdings are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Change To Liabilities i.e., Cardio Diagnostics' Change To Liabilities and End Period Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.73 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Change To Liabilities
End Period Cash Flow
Most indicators from Cardio Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cardio Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Cardio Diagnostics' Selling General Administrative is very stable compared to the past year. As of the 11th of December 2024, Enterprise Value is likely to grow to about 37.3 M, while Issuance Of Capital Stock is likely to drop 0.00.
| 2021 | 2023 | 2024 (projected) | Reconciled Depreciation | 16K | 53.8K | 56.5K | Total Operating Expenses | 621.3K | 7.3M | 7.6M |
Cardio Diagnostics fundamental ratios Correlations
Click cells to compare fundamentals
Cardio Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Cardio Diagnostics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardio Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will appreciate offsetting losses from the drop in the long position's value.Moving against Cardio Stock
| 0.5 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.47 | SLS | Sellas Life Sciences | PairCorr |
| 0.41 | GNFT | Genfit | PairCorr |
| 0.39 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.38 | VALN | Valneva SE ADR | PairCorr |
The ability to find closely correlated positions to Cardio Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardio Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardio Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardio Diagnostics Holdings to buy it.
The correlation of Cardio Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardio Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardio Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardio Diagnostics. If investors know Cardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.30) | Revenue Per Share 0.002 | Quarterly Revenue Growth 3.562 | Return On Assets (0.98) | Return On Equity (2.93) |
The market value of Cardio Diagnostics is measured differently than its book value, which is the value of Cardio that is recorded on the company's balance sheet. Investors also form their own opinion of Cardio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Cardio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardio Diagnostics' market value can be influenced by many factors that don't directly affect Cardio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardio Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.